ABCB6 and chronic myelogenous leukemia, BCR-ABL1 positive: The alteration of different signaling pathways such as cell cycle, JAK-STAT, and the deregulation of ABC drug efflux transporters can promote the development of growth and survival of CML progenitor and stem cells [1].